Growth Metrics

Novartis Ag (NVS) Change in Working Capital (2016 - 2025)

Historic Change in Working Capital for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to -$1.6 billion.

  • Novartis Ag's Change in Working Capital fell 3184000.0% to -$1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.6 billion, marking a year-over-year decrease of 12337.11%. This contributed to the annual value of -$1.6 billion for FY2025, which is 12337.11% down from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Change in Working Capital is -$1.6 billion, which was down 3184000.0% from $1.3 billion recorded in Q3 2025.
  • Over the past 5 years, Novartis Ag's Change in Working Capital peaked at $1.3 billion during Q3 2025, and registered a low of -$2.0 billion during Q1 2022.
  • Its 5-year average for Change in Working Capital is -$178.6 million, with a median of $92.5 million in 2021.
  • Per our database at Business Quant, Novartis Ag's Change in Working Capital surged by 123611.11% in 2021 and then tumbled by 3184000.0% in 2025.
  • Novartis Ag's Change in Working Capital (Quarter) stood at $1.2 billion in 2021, then plummeted by 61.22% to $456.0 million in 2022, then crashed by 184.21% to -$384.0 million in 2023, then soared by 101.3% to $5.0 million in 2024, then crashed by 31840.0% to -$1.6 billion in 2025.
  • Its Change in Working Capital was -$1.6 billion in Q4 2025, compared to $1.3 billion in Q3 2025 and $442.0 million in Q2 2025.